Brief: Resonance Health Says Mitchell Wells To Transition To Role Of MD
28/06/2021 02:09
June 28 (Reuters) - Resonance Health Ltd RHT.AX :
* MITCHELL WELLS TO TRANSITION TO ROLE OF MD, FROM CURRENT
ROLE AS
EXECUTIVE DIRECTOR
Source text for Eikon: ID:nASXbR7FzF
Further company coverage: RHT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Resonance Health
See all newsAustralia's Resonance Health jumps on FY26 forecast hike
Brief: Resonance Health Expects FY26 Underlying EBITDA A$2.6 Mln
Brief: Resonance Health Says Martin Blake Retires As Chair
Brief: Resonance Health Contracted For Clinical Drug Trial Worth A$13.775 Mln
Brief: Resonance Seeks Trading Halt Pending Announcement On Execution Of Contract For Services For Clinical Trial By Pharma Co